Product Information
SYMPAZAN 20 MG FILM is a brand product labeled by Aquestive Therapeutics, priced at $65.4282 per EA under NDC 10094022060. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 1, 2018.
The High Outlier badge above means this manufacturer's average price in the clobazam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
Aquestive TherapeuticsNDC
10094022060
Classification
Brand
Dosage Form
FILM
Route
ORAL
Effective Date
4/1/2026
Active Ingredients
CLOBAZAMApproval Type
New Drug (NDA)
FDA Application
NDA210833FDA Approved
11/1/2018
On Market Since
11/1/2018
Pharmacological Classes
Price Statistics
The NADAC for SYMPAZAN 20 MG FILM has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $65.4282 per EA |
|---|---|
| All-time high | $65.4282 (Sep 30, 2026) |
| All-time low | $62.3729 (Jan 22, 2025) |
| 52-week high | $65.4282 |
| 52-week low | $64.0451 |
| Median price | $64.2082 |
| Average price | $63.8662 |
| Largest weekly change | +2.9% (Apr 9, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clobazam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aquestive Therapeutics manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clobazam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYMPAZAN 20 MG FILM?
The current National Average Drug Acquisition Cost (NADAC) for SYMPAZAN 20 MG FILM, manufactured by Aquestive Therapeutics, is $65.4282 per EA (NDC 10094022060), effective Sep 30, 2026.
How has the price of SYMPAZAN 20 MG FILM changed over time?
Over the history we have for it, the NADAC for SYMPAZAN 20 MG FILM has risen 4.4%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for SYMPAZAN 20 MG FILM?
Since Apr 17, 2024, the NADAC for SYMPAZAN 20 MG FILM has ranged from a low of $62.3729 (Jan 22, 2025) to a high of $65.4282 (Sep 30, 2026), with a median of $64.2082 per EA.
Are there cheaper alternatives to SYMPAZAN 20 MG FILM?
No other NADAC-published product currently shares the active ingredient and strength of SYMPAZAN 20 MG FILM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SYMPAZAN 20 MG FILM?
SYMPAZAN 20 MG FILM (NDC 10094022060) is labeled by Aquestive Therapeutics, and CMS classifies it as a brand product.